Shilanski & Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$170K Sell
10,115
-133
-1% -$2.23K 0.05% 108
2025
Q1
$158K Buy
10,248
+459
+5% +$7.06K 0.05% 104
2024
Q4
$216K Buy
+9,789
New +$216K 0.07% 98